(Q46341976)

21 December 2017

title

Treating women with HIV: is it different than treating men? (English)

1 reference

21 December 2017

author name string

Mariam Aziz

series ordinal

1

1 reference

21 December 2017

Kimberly Y Smith

series ordinal

2

1 reference

21 December 2017

publication date

1 June 2012

1 reference

21 December 2017

published in

Current HIV/AIDS reports

1 reference

21 December 2017

volume

9

1 reference

21 December 2017

issue

2

1 reference

21 December 2017

page(s)

171-178

1 reference

21 December 2017

https://scigraph.springernature.com/pub.10.1007/s11904-012-0116-x

exact match

0 references

cites work

Association of child care burden and household composition with adherence to highly active antiretroviral therapy in the Women's Interagency HIV Study

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0116-X

The impact of competing subsistence needs and barriers on access to medical care for persons with human immunodeficiency virus receiving care in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0116-X

Effects of depressive symptoms and mental health quality of life on use of highly active antiretroviral therapy among HIV-seropositive women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0116-X

Use of highly active antiretroviral therapy in a cohort of HIV-seropositive women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0116-X

Mortality, CD4 cell count decline, and depressive symptoms among HIV-seropositive women: longitudinal analysis from the HIV Epidemiology Research Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0116-X

Pharmacokinetic interactions between etravirine and non-antiretroviral drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0116-X

Sex and the course of HIV infection in the pre- and highly active antiretroviral therapy eras

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0116-X

Race and sex differences in antiretroviral therapy use and mortality among HIV-infected persons in care.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0116-X

Effect of baseline- and treatment-related factors on immunologic recovery after initiation of antiretroviral therapy in HIV-1-positive subjects: results from ACTG 384.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0116-X

Comparison of sequential three-drug regimens as initial therapy for HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0116-X

Class-sparing regimens for initial treatment of HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0116-X

Randomized, double-blind, placebo-matched, multicenter trial of abacavir/lamivudine or tenofovir/emtricitabine with lopinavir/ritonavir for initial HIV treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0116-X

Highly active antiretroviral therapy in a large urban clinic: risk factors for virologic failure and adverse drug reactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0116-X

Once-daily atazanavir/ritonavir versus twice-daily lopinavir/ritonavir, each in combination with tenofovir and emtricitabine, for management of antiretroviral-naive HIV-1-infected patients: 48 week efficacy and safety results of the CASTLE study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0116-X

Once-daily darunavir/ritonavir vs. lopinavir/ritonavir in treatment-naive, HIV-1-infected patients: 96-week analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0116-X

Sex differences in HAART-associated dyslipidaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0116-X

A high incidence of lactic acidosis and symptomatic hyperlactatemia in women receiving highly active antiretroviral therapy in Soweto, South Africa.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0116-X

Sex differences in nevirapine rash

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0116-X

Female sex but not ethnicity is a strong predictor of non-nucleoside reverse transcriptase inhibitor-induced rash

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0116-X

Severe hepatotoxicity associated with nevirapine use in HIV-infected subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0116-X

Maternal toxicity with continuous nevirapine in pregnancy: results from PACTG 1022.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0116-X

Hepatotoxicity associated with long- versus short-course HIV-prophylactic nevirapine use: a systematic review and meta-analysis from the Research on Adverse Drug events And Reports (RADAR) project.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0116-X

Sex differences in lopinavir and ritonavir pharmacokinetics among HIV-infected women and men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0116-X

Effects of darunavir/ritonavir-based therapy on metabolic and anthropometric parameters in women and men over 48 weeks

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0116-X

Evaluation of sex differences of fosamprenavir (with and without ritonavir) in HIV-infected men and women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0116-X

Factors associated with mother-to-child transmission of HIV-1 despite a maternal viral load <500 copies/ml at delivery: a case-control study nested in the French perinatal cohort (EPF-ANRS CO1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0116-X

Safety of efavirenz in first-trimester of pregnancy: a systematic review and meta-analysis of outcomes from observational cohorts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0116-X

Birth defects among children born to human immunodeficiency virus-infected women: pediatric AIDS clinical trials protocols 219 and 219C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0116-X

Safety of efavirenz in the first trimester of pregnancy: an updated systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0116-X

Quantifying the risks and benefits of efavirenz use in HIV-infected women of childbearing age in the USA

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0116-X

Efficacy and safety of once-daily nevirapine- or efavirenz-based antiretroviral therapy in HIV-associated tuberculosis: a randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0116-X

Increased risk of preterm delivery among HIV-infected women randomized to protease versus nucleoside reverse transcriptase inhibitor-based HAART during pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0116-X

Prevention of HIV-1 infection with early antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0116-X

Postpartum viral load rebound in HIV-1-infected women treated with highly active antiretroviral therapy: AIDS Clinical Trials Group Protocol A5150.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0116-X

Quality of life among women living with HIV: the importance violence, social support, and self care behaviors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0116-X

Failure to Establish HIV Care: Characterizing the "No Show" Phenomenon

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0116-X

Sex differences in adverse reactions to antiretroviral drugs.

21 January 2018

1 reference

12 December 2020

Vital signs: HIV prevention through care and treatment--United States.

1 reference

12 December 2020

Higher rates of bone loss in postmenopausal HIV-infected women: a longitudinal study

1 reference

12 December 2020

Sex-based outcomes of darunavir-ritonavir therapy: a single-group trial

1 reference

12 December 2020

Differences between women and men in adverse events and CD4+ responses to nucleoside analogue therapy for HIV infection. The Aids Clinical Trials Group 175 Team

1 reference

12 December 2020

Medically eligible women who do not use HAART: the importance of abuse, drug use, and race

1 reference

12 December 2020

Safety, efficacy, and pharmacokinetics of rilpivirine: systematic review with an emphasis on resource-limited settings

1 reference

12 December 2020

Lack of increased hepatotoxicity in HIV-infected pregnant women receiving nevirapine compared with other antiretrovirals

1 reference

12 December 2020

Are there gender differences in starting protease inhibitors, HAART, and disease progression despite equal access to care?

1 reference

12 December 2020

A risk-factor guided approach to reducing lactic acidosis and hyperlactatemia in patients on antiretroviral therapy

1 reference

12 December 2020

Occupational stigma as a primary barrier to health care for street-based sex workers in Canada

1 reference

12 December 2020

Fat distribution in women with HIV infection

1 reference

12 December 2020

Association of race, substance abuse, and health insurance coverage with use of highly active antiretroviral therapy among HIV-infected women, 2005

1 reference

12 December 2020

Sex differences in nevirapine rash

1 reference

12 December 2020

Combination antiretroviral therapy with protease inhibitors in HIV-infected pregnancy

1 reference

12 December 2020

Delays in seeking HIV care due to competing caregiver responsibilities

1 reference

12 December 2020

Virologic, Immunologic, and Clinical Response to Highly Active Antiretroviral Therapy: the Gender Issue Revisited

1 reference

12 December 2020

Differential gender effects of depression on use of HIV medications among HIV-positive Puerto Rican drug users

1 reference

12 December 2020

10.1007/S11904-012-0116-X

Identifiers

DOI

1 reference

21 December 2017

1 reference

21 December 2017